期刊文献+

格列卫新辅助治疗晚期胃肠间质瘤28例 被引量:1

下载PDF
导出
摘要 胃肠间质瘤(stromal gastrointestinal tumorGIST)是一种常见的消化道原始间叶组织的肿瘤外科切除是目前治疗GIST的"金标准"[1]。针对体积较大、病期较晚、手术无法切除或远处转移的GIST,格列卫是最有效的治疗药物。我院2004年1月—2010年1月收治晚期GIST 28例,采用格列卫新辅助治疗,总结报道如下。
出处 《中国现代普通外科进展》 CAS 2010年第6期497-498,共2页 Chinese Journal of Current Advances in General Surgery
  • 相关文献

参考文献8

  • 1詹文华,王鹏志,邵永孚,伍晓汀,顾晋,李荣,万德森,丁克峰,师英强,于吉人,卢辉山,邹小明,毕建威,孙益红,陆云飞,陈道达,张信华.伊马替尼术后辅助治疗胃肠间质瘤的多中心前瞻性临床试验中期报告[J].中华胃肠外科杂志,2006,9(5):383-387. 被引量:85
  • 2方育,李非,李嘉,崔宏力,王亚军.格列卫新辅助治疗晚期恶性胃间质瘤[J].实用医学杂志,2006,22(16):1921-1923. 被引量:5
  • 3Blay J,Bonvalot S,Casali P,et al.Consensus meeting for the management of gastrointestinal stromal tumors Report of the GIST Consensus Conference of 20-21 March 2004,under the auspices of ESMO[J].Annals of Oncology 2005,16(4):566.
  • 4Rossi C,Mocellin S,Mencarelli R,et al.Gastrointestinal stromal tumors:from a surgical to a molecular approach[J].International Journal of Cancer,2003,107(2):171-176.
  • 5吴伟.胃间质瘤的外科治疗(附40例报告)[J].实用临床医药杂志,2008,12(4):71-73. 被引量:8
  • 6Blanke C,Demetri G,von Mehren M,et al.Long-term results from a randomized phase Ⅱ trial of standard-versus higher-dose Gleevec mesylate for patients with unresectable or metastatic gastrointestinal stromal tumors expressing KIT[J].Journal of Clinical Oncology,2008,26(4):620.
  • 7王一飞,殷保兵,马保金.胃肠道间质瘤诊治进展(文献综述)[J].国外医学(外科学分册),2004,31(3):176-179. 被引量:24
  • 8Bümming P,Andersson J,Meis-Kindblom J,et al.Neoadjuvant,adjuvant and palliative treatment of gastrointestinal stremal tumanrs(GIST)with imatinib:a centre-based study of 17 patients[J].British Journal of Cancer,2003,89(3):460-464.

二级参考文献68

  • 1蒋晖.cyclinB1、Ki-67在胃癌中的表达及其关系[J].实用临床医药杂志,2007,11(2):83-84. 被引量:5
  • 2DEMATTEO R P, LEWIS J J, Leung D, et al. Two hundred gastrointestinal stromal tumors: recurrence patterns and prognostic factors for survival [J]. Ann Surg, 2000, 231(1): 51-58.
  • 3MIETTINEN M, LASOTA J. Gastrointestinal stromal tumorsdefinition, clinical, histological, immunohistochemical, and molecular genetic features and differential diagnosis [J] . Virchows Arch, 2001, 438(1): 1-12.
  • 4FLETCHER C D, BERMAN J J, CORLESS C, et al. Diagnosis of gastrointestinal stromal tumors: A consensus approach [J] . Hum Pathol 2002,33 (5): 459 - 465.
  • 5SCAIFE C L,HUNT K K,PATEL S R,et al. Is there a role for surgery in patients with "unresectable" cKIT-gastrointestinal stromal tumors treated with imatinib mesylate [J]? Am J Surg,2003,186(6) :665 -669.
  • 6HIROTA S, ISOZAKI K, MORIYAMA Y, et al. Gain-of-function mutations of c-KIT in human gastrointestinal stromal tumors [J] .Science, 1998, 279(5350): 577 - 580.
  • 7KINDBLOM L G, REMOTTI H E, ALDENBORG F, et al.Gastrointestinal pacemaker cell tumor (GIPACT): gastrointestinal stromal tumors show phenotypic characteristics of the intestinal cells of Cajal [J]. Am J Pathol, 1998, 152(5): 1259 - 1269.
  • 8CROSBY J A, CATFON C N, DAVIS A, et al. Malignant gastrointestinal stromal tumors of the small intestine: a review of 50 cases from a prospective database [J]. Ann Surg Oncol, 2001, 8(1):50 - 59.
  • 9MIETTINEN M, EL-RIFAI W, H L SOBIN L, et al. Evaluation of malignancy and prognosis of gastrointestinal stromal tumors: a review [J]. Hum Pathol, 2002, 33(5): 478-483.
  • 10PIDHORECKY I, CHENEY R T, KRAYBILL W G, et al.Gastrointestinal stromal tumors: current diagnosis, biologic behavior,and management [J]. Ann Surg Oncol, 2000,7(9):705 -712.

共引文献118

同被引文献9

  • 1Brimming P, Andersson J, Meis-Kindblom JM, et al. Neoadjuvant, adjuvant and palliative therapy of gastrointestinal stromal tumours (GIST) with imatinib: a centrebased study of 17 patients[J]. BrJ Cancer, 2003, 89(3): 460-464.
  • 2McAuliffe JC, Hunt KK, Lazar AJ, et al. A randomized phase II study of preoperative plus postoperative imatinib in GIST: evidence of rapid radiographic response and temporal induction of tumor cell apoptosis[J]. Ann Surg Oncol, 2009, 16(4): 910- 919.
  • 3Blanke CD, Demetri GD, yon Mehren M, et al. Long-term results from a randomized phase II trial of standard- versus higher-dose imatinib mesylate for patients with unresectable or metastatic gastrointestinal stromal tumors expressing KIT [J]. J Clin Oncol, 2008, 26(4): 620-625.
  • 4Demetri GD, yon Mehren M, Blanke CD, et aL Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors [J]. N Engl J Med, 2002, 347(7): 472-480.
  • 5顾晋,姚云峰.胃肠间质瘤新辅助与术后辅助治疗[J].中华普通外科学文献(电子版),2008,2(4):5-7. 被引量:3
  • 6师英强.胃肠间质瘤的外科及靶向治疗策略[J].中国实用外科杂志,2010,30(7):547-550. 被引量:2
  • 7胡永宏,廖江泰.胃肠道间质瘤新进展[J].甘肃医药,2012,31(3):190-194. 被引量:1
  • 8张艳霞,章培军,闫燕艳,段爱旭,李加善,牛三强.Ki-67、PCNA和Survivin在胃肠道间质瘤组织中的表达[J].山东大学学报(医学版),2013,51(1):67-70. 被引量:7
  • 9沈友辉.胃肠道间质瘤32例临床分析[J].武警后勤学院学报(医学版),2014,23(10):847-848. 被引量:2

引证文献1

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部